Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Open accessThe DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) infection has emerged in patients who do not have the established risk factors. The national burden and clinical effect of this novel presentation of MRSA disease are unclear. METHODS: We evaluated MRSA infections in patients identified from population-based surveillance in Baltimore and Atlanta and from hospital-laboratory-based sentinel surveillance of 12 hospitals in Minnesota. Information was obtained by interviewing patients and by reviewing their medical records. Infections were classified as community-associated [correction] MRSA disease if no established risk factors were identified. RESULTS: From 2001 through 2002, 1647 cases of community-associated [correction] MRSA infection were reported, representing between 8 and 20 percent of all MRSA isolates. The annual disease incidence varied according to site (25.7 cases per 100,000 population in Atlanta vs. 18.0 per 100,000 in Baltimore) and was significantly higher among persons less than two years old than among those who were two years of age or older (relative risk, 1.51; 95 percent confidence interval, 1.19 to 1.92) and among blacks than among whites in Atlanta (age-adjusted relative risk, 2.74; 95 percent confidence interval, 2.44 to 3.07). Six percent of cases were invasive, and 77 percent involved skin and soft tissue. The infecting strain of MRSA was often (73 percent) resistant to prescribed antimicrobial agents. Among patients with skin or soft-tissue infections, therapy to which the infecting strain was resistant did not appear to be associated with adverse patient-reported outcomes. Overall, 23 percent of patients were hospitalized for the MRSA infection. CONCLUSIONS: Community-associated MRSA infections are now a common and serious problem. These infections usually involve the skin, especially among children, and hospitalization is common.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current epidemic of CA-MRSA in the United States and elsewhere disproportionally affects individuals of African descent with severe and invasive infections (Fridkin et al., 2005).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Fridkin et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Naimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
The Changing Epidemiology of Staphylococcus aureus?
Chambers, H. F. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010204 · Cited by 1,495
Herold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412
Diekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362
Methicillin-Resistant Staphylococcus aureus
Brumfitt, W., & Hamilton-Miller, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905043201806 · Cited by 934
Staphylococcus aureus: A Well–Armed Pathogen
Archer, G. L. (1998) · Clinical Infectious Diseases · doi:10.1086/520289 · Cited by 658
Lorenz, E., Mira, J. P., Cornish, K. L., Arbour, N. C., & Schwartz, D. A. (2000) · Infection and Immunity · doi:10.1128/.68.11.6398-6401.2000 · Cited by 598
Research works printed but not linked: 5
- Methicillin-resistant Staphylococcus aureus infections in correctional facilities -Geor- gia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep 2003;52: 992-6.
- Methicillin-resistant Staphylococcus aureus infections among competitive sports par- ticipants -Colorado, Indiana, Pennsylva- nia, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep 2003;52: 793-5.
- Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections -Los Angeles County, Califor- nia, 2002-2003. MMWR Morb Mortal Wkly Rep 2003;52:88.
- Community-associated methicillin- resistant Staphylococcus aureus infections in Pacific Islanders -Hawaii, 2001-2003. MMWR Morb Mortal Wkly Rep 2004;53: 767-70.
- Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison -Mississippi, 2000. MMWR Morb Mortal Wkly Rep 2001;50:919-22.
Cited by
Items 301–400 of 1,000
DERAMO, V. A., Lai, J. C., Winokur, J. A., Luchs, J., & Udell, I. J. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.10.020 · Cited by 66
Wang, X., Towers, S., Panchanathan, S., & Chowell, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060872 · Cited by 64
Phenotypic Prediction Rule for Community-Associated Methicillin-Resistant Staphylococcus aureus
Popovich, K., Hota, B., Rice, T., Aroutcheva, A., & Weinstein, R. A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00044-07 · Cited by 67
Methicillin-resistant Staphylococcus aureus in HIV-infected patients
Hidrón, A., Moanna, A., Kempker, R. R., & Rimland, D. (2010) · Infection and Drug Resistance · doi:10.2147/idr.s7641 · Cited by 73
Changing needs of community-acquired pneumonia
Ramírez, J. A., & Anzueto, A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr094 · Cited by 73
Giudice, P. D., Blanc, V., Durupt, F., Bes, M., Martinez, J.-P., Counillon, E., Lina, G., Vandenesch, F., & Étienne, J. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06910.x · Cited by 84
Management of Skin and Soft-Tissue Infections in the Emergency Department
Abrahamian, F. M., Talan, D. A., & Moran, G. J. (2008) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2007.12.001 · Cited by 70
Mohammad, H. T., Younis, W., Ezzat, H. G., Peters, C. E., AbdelKhalek, A., Cooper, B. R., Pogliano, K., Pogliano, J., Mayhoub, A. S., & Seleem, M. N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182821 · Cited by 69
Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections
Ellis, M. W., & Lewis, J. S. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000186850.54040.fc · Cited by 70
Wang, X., Ip, M., Leung, A. W., & Xu, C. (2014) · Ultrasonics · doi:10.1016/j.ultras.2014.06.017 · Cited by 64
How much ozone bactericidal activity is compromised by plasma components?
Burgassi, S., Zanardi, I., Travagli, V., Montomoli, E., & Bocci, V. A. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2008.04141.x · Cited by 75
Targeting MgrA-Mediated Virulence Regulation in Staphylococcus aureus
Sun, F., Zhou, L., Zhao, B.-C., Deng, X., Cho, H., Yi, C., Jian, X., Song, C., Luan, C.-H., Bae, T., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.05.014 · Cited by 67
Brackman, G., Meyer, L. D., Nelis, H. J. C. F., & Coenye, T. (2013) · Journal of Applied Microbiology · doi:10.1111/jam.12191 · Cited by 72
Casey, J. A., Cosgrove, S. E., Stewart, W. F., Pollak, J., & Schwartz, B. S. (2012) · Epidemiology and Infection · doi:10.1017/s0950268812001872 · Cited by 74
Boyle‐Vavra, S., Jones, M. B., Gourley, B. L., Holmes, M. H., Ruf, R. A. S., Balsam, A. R., Boulware, D. R., Kline, S., Jawahir, S., DeVries, A., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01593-10 · Cited by 69
Twenty Years of Active Bacterial Core Surveillance
Langley, G., Schaffner, W., Farley, M. M., Lynfield, R., Bennett, N. M., Reingold, A. L., Thomas, A. R., Harrison, L. H., Nichols, M. C., Petit, S., et al. (2015) · Emerging infectious diseases · doi:10.3201/eid2109.141333 · Cited by 68
Self-citationPark, K., Chong, Y. P., Kim, S., Lee, S., Choi, S., Lee, M. S., Jeong, J., Woo, J. H., & Kim, Y. S. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.07.026 · Cited by 63
In Vitro and In Vivo Antibacterial Activities of DC-159a, a New Fluoroquinolone
Hoshino, K., Inoue, K., Murakami, Y., Kurosaka, Y., Namba, K., Kashimoto, Y., Uoyama, S., Okumura, R., Higuchi, S., & Otani, T. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00853-07 · Cited by 63
Tong, S. Y. C., van Hal, S. J., Einsiedel, L. J., Currie, B. J., & Turnidge, J. D. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-249 · Cited by 63
Yanagihara, K., Tashiro, M., Fukuda, Y., Ohno, H., Higashiyama, Y., Miyazaki, Y., Hirakata, Y., Tomono, K., Mizuta, Y., Tsukamoto, K., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki416 · Cited by 69
Chen, A. E., Goldstein, M., Carroll, K., Song, X., Perl, T. M., & Siberry, G. K. (2006) · Pediatric Emergency Care · doi:10.1097/01.pec.0000236832.23947.a0 · Cited by 64
MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003
Wyllie, D. H., Peto, T., & Crook, D. W. (2005) · BMJ · doi:10.1136/bmj.38558.453310.8f · Cited by 68
Methamphetamine Use and Methicillin-Resistant Staphylococcus aureus Skin Infections
Cohen, A. L., Shuler, C., McAllister, S., Fosheim, G. E., Brown, M. G., Abercrombie, D., Anderson, K., McDougal, L. K., Drenzek, C., Arnold, K., et al. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1311.070148 · Cited by 64
Pharmacological Profile of Quinoxalinone
Ramli, Y., Moussaif, A., Karrouchi, K., & Essassi, E. M. (2014) · Journal of Chemistry · doi:10.1155/2014/563406 · Cited by 62
Hatcher, S. M., Rhodes, S., Stewart, J. R., Silbergeld, E. K., Pisanic, N., Larsen, J., Jiang, S., Krosche, A., Hall, D., Carroll, K. C., et al. (2016) · Environmental Health Perspectives · doi:10.1289/ehp35 · Cited by 83
Milstone, A. M., Carroll, K. C., Ross, T. L., Shangraw, K. A., & Perl, T. M. (2010) · Emerging infectious diseases · doi:10.3201/eid1604.090107 · Cited by 63
Second-Generation Phenylthiazole Antibiotics with Enhanced Pharmacokinetic Properties
Seleem, M. A., Disouky, A., Mohammad, H. T., Abdelghany, T. M., Mancy, A. S., Bayoumi, S. A., Elshafeey, A. H., El-morsy, A., Seleem, M. N., & Mayhoub, A. S. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00233 · Cited by 62
Kaplan, S. L. (2005) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2005.05.011 · Cited by 60
Modelling an outbreak of an emerging pathogen
Kajita, E., Okano, J. T., Bodine, E. N., Layne, S. P., & Blower, S. M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1660 · Cited by 66
Rodríguez‐Baño, J., Bischofberger, C., Álvarez-Lerma, F., Asensio, Á., Delgado, T., García-Arcal, D., García-Ortega, L., Hernández, M., Molina‐Cabrillana, J., Pérez-Canosa, C., et al. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13120418 · Cited by 82
Jappe, U., Heuck, D., Strommenger, B., Wendt, C., Werner, G., Altmann, D., & Witte, W. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.133 · Cited by 68
Dubouix-Bourandy, A., de Ladoucette, A., Pietri, V., Mehdi, N., Benzaquen, D., Guinand, R., & Gandois, J.-M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00334-11 · Cited by 60
Branco, T. M., Valério, N., Jesus, V. I. R., Dias, C. J., Neves, M. G. P. M. S., Faustino, M. A. F., & Almeida, A. (2018) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2018.01.001 · Cited by 62
Park, C., Lee, D., Kim, S. W., Choi, S., Park, S. H., Chun, H., Choi, J., Yoo, J., Shin, W. S., Kang, J. H., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01147-07 · Cited by 65
Kilic, A., Li, H., Stratton, C. W., & Tang, Y.-W. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01546-06 · Cited by 61
Contrasting Pediatric and Adult Methicillin-resistant Staphylococcus aureus Isolates
David, M. Z., Crawford, S. E., Boyle‐Vavra, S., Hostetler, M. A., Kim, D. C., & Daum, R. S. (2006) · Emerging infectious diseases · doi:10.3201/eid1204.050960 · Cited by 73
Evolving Epidemiology ofStaphylococcus aureusBacteremia
Rhee, Y., Aroutcheva, A. A., Hota, B. N., Weinstein, R. A., & Popovich, K. J. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.213 · Cited by 64
Małachowa, N., Kobayashi, S. D., Porter, A. R., Braughton, K. R., Scott, D. P., Gardner, D. J., Missiakas, D. M., Schneewind, O., & DeLeo, F. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158293 · Cited by 66
Gupta, V., Hegde, A. V., Ahdal, J., Qamra, A., Motlekar, S. A., & Jain, R. (2019) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23337 · Cited by 59
Inappropriate Antibiotic Use in Soft Tissue Infections
Paydar, K. Z., Hansen, S. L., Charlebois, E. D., Harris, H. W., & Young, D. M. (2006) · Archives of Surgery · doi:10.1001/archsurg.141.9.850 · Cited by 61
Dihydrofolate Reductase (DHFR) Inhibitors: A Comprehensive Review
Sehrawat, R., Rathee, P., Khatkar, S., Akkol, E., Khayatkashani, M., Nabavi, S. M., & Khatkar, A. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230310091510 · Cited by 79
Kujath, P., & Kujath, C. (2010) · European journal of medical research · doi:10.1186/2047-783x-15-12-544 · Cited by 61
Epidemiology and risk factors for Staphylococcus aureuscolonization in children in the post-PCV7 era
Lee, G. M., Huang, S. S., Rifas‐Shiman, S. L., Hinrichsen, V. L., Pelton, S. I., Kleinman, K., Hanage, W. P., Lipsitch, M., McAdam, A. J., & Finkelstein, J. A. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-110 · Cited by 67
Labreche, M. J., Lee, G. C., Attridge, R. T., Mortensen, E. M., Koeller, J. M., Du, L. C., Nyren, N. R., Trevino, L. B., Trevino, S. B., Pena, J., et al. (2013) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2013.05.120247 · Cited by 62
Empirical therapy in Methicillin-resistant Staphylococcus Aureus infections: An Up-To-Date approach
VanEperen, A. S., & Segreti, J. (2016) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2016.02.012 · Cited by 69
Durand, G., Javerliat, F., Bes, M., Veyrieras, J., Guigon, G., Mugnier, N., Schicklin, S., Kaneko, G., Santiago-Allexant, E., Bouchiat, C., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00511 · Cited by 58
Risk factors for bacteremia in patients with limb cellulitis
Peralta, G., Padron, E., Mesones, M. P. R., de Benito, I., Garrido, J. C., Talledo, F., Rodríguez-Lera, M. J., Ansorena, L. G., & Sánchez, M. B. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0186-z · Cited by 58
Harro, C., Betts, R., Orenstein, W., Kwak, E.-J., Greenberg, H. E., Onorato, M. T., Hartzel, J., Lipka, J., DiNubile, M. J., & Kartsonis, N. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00356-10 · Cited by 57
Nigo, M., Rasmy, L., Mao, B., Kannadath, B. S., Xie, Z., & Zhi, D. (2024) · Nature Communications · doi:10.1038/s41467-024-46211-0 · Cited by 64
Azarian, T., Cook, R. L., Johnson, J. A., Guzman, N., McCarter, Y. S., Gomez, N., Rathore, M. H., Morris, J. G., & Salemi, M. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.73 · Cited by 57
Ray, G. T., Suaya, J. A., & Baxter, R. P. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00134-12 · Cited by 64
Orscheln, R. C., Hunstad, D. A., Fritz, S. A., Loughman, J. A., Mitchell, K. J., Storch, E. K., Gaudreault‐Keener, M., Sellenriek, P., Armstrong, J. R., Mardis, E. R., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/600881 · Cited by 64
Kranjec, C., Ovchinnikov, K. V., Grønseth, T., Ebineshan, K., Srikantam, A., & Diep, D. B. (2020) · npj Biofilms and Microbiomes · doi:10.1038/s41522-020-00166-4 · Cited by 67
Bratu, S., Landman, D., Gupta, J., Trehan, M., Panwar, M., & Quale, J. M. (2006) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-5-29 · Cited by 68
Cutaneous Manifestations of Human Immunodeficiency Virus: a Clinical Update
Altman, K., Vanness, E. R., & Westergaard, R. P. (2015) · Current Infectious Disease Reports · doi:10.1007/s11908-015-0464-y · Cited by 56
Trends in Resource Utilization for Hospitalized Children With Skin and Soft Tissue Infections
Lopez, M. A., Cruz, A. T., Kowalkowski, M. A., & Raphael, J. L. (2013) · PEDIATRICS · doi:10.1542/peds.2012-0746 · Cited by 58
(2009) · Europe PMC (PubMed Central)
Madureira, A. R., Pereira, A. B., & Pintado, M. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.05.030 · Cited by 60
Ossowski, K., Chun, R. H., Suskind, D. L., & Baroody, F. M. (2006) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.132.11.1176 · Cited by 58
Moore, C. L., Hingwe, A. S., Donabedian, S. M., Perri, M. B., Davis, S. L., Haque, N. Z., Reyes, K., Vager, D. L., & Zervos, M. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.03.004 · Cited by 62
Prosperi, M., Véras, N. M. C., Azarian, T., Rathore, M. H., Nolan, D. J., Rand, K. H., Cook, R. L., Johnson, J., Morris, J. G., & Salemi, M. (2013) · Scientific Reports · doi:10.1038/srep01902 · Cited by 57
Kolla, H. B., Tirumalasetty, C., Sreerama, K., & Ayyagari, V. S. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00160-z · Cited by 63
Harro, C. D., Betts, R. F., Hartzel, J. S., Onorato, M. T., Lipka, J., Smugar, S. S., & Kartsonis, N. A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.12.045 · Cited by 56
Abu-Shanab, B., Adwan, G., Jarrar, N., Abu-Hijleh, A., & Adwan, K. (2006) · DergiPark (Istanbul University) · Cited by 55
Olson, Donnenfeld, E. D., Bucci, Price, Raizman, Solomon, Devgan, Trattler, W., Dell, Wallace, et al. (2010) · Clinical ophthalmology · doi:10.2147/opth.s14333 · Cited by 55
Nasal carriage of methicillin-resistant Staphylococcus aureus in university students
Prates, K. A., Torres, A. M., Garcia, L. B., Yamada‐Ogatta, S. F., Cardoso, C. L., & Tognim, M. C. B. (2010) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(10)70064-7 · Cited by 64
Ma, X., Chang, W., Zhang, C., Zhou, X., & Yu, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034970 · Cited by 66
Wright, C. T., Stocks, R. M. S., Armstrong, D. L., Arnold, S. R., & Gould, H. J. (2008) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.134.4.408 · Cited by 54
Daptomycin: rationale and role in the management of skin and soft tissue infections
Seaton, R. A. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn368 · Cited by 59
Wang, S., Sun, Z., Guo, Y., Yang, B., Yuan, Y., Wei, Q., & Ye, K. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.020537-0 · Cited by 62
High-dose trimethoprim-sulfamethoxazole and clindamycin for Staphylococcus aureus endocarditis
Tissot‐Dupont, H., Gouriet, F., Oliver, L., Jamme, M., Casalta, J., Jimeno, M.-T., Arregle, F., Lavoûte, C., Hubert, S., Philip, M., et al. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.06.006 · Cited by 57
Community acquired bacterial pneumonia
Anevlavis, S., & Bouros, D. E. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903508770 · Cited by 68
Parta, M., Goebel, M. C., Matloobi, M., Stager, C. E., & Musher, D. M. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00351-09 · Cited by 54
Treatment of complicated intra-abdominal infections in the era of multi-drug resistant Bacteria
Herzog, T., Chromik, A., & Uhl, W. (2010) · European journal of medical research · doi:10.1186/2047-783x-15-12-525 · Cited by 53
Elsahn, A. F., Yildiz, E. H., Jungkind, D. L., Abdalla, Y. F., Erdurmuş, M., Cremona, F. A., Rapuano, C. J., Hammersmith, K. M., & Cohen, E. J. (2010) · Cornea · doi:10.1097/ico.0b013e3181d2ce25 · Cited by 54
Hospitalist Perspective on the Treatment of Skin and Soft Tissue Infections
Amin, A., Cerceo, E. A., Deitelzweig, S. B., Pile, J. C., Rosenberg, D. J., & Sherman, B. M. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.04.018 · Cited by 59
A review of hand‐washing techniques in primary care and community settings
Smith, S. M. S. (2009) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2008.02546.x · Cited by 67
Cadilla, A., David, M. Z., Daum, R. S., & Boyle-Vavra, S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00759-10 · Cited by 52
Gagarinov, I. A., Fang, T., Liu, L., Srivastava, A. D., & Boons, G. (2015) · Organic Letters · doi:10.1021/acs.orglett.5b00031 · Cited by 59
Whole Genome Sequencing—Implications for Infection Prevention and Outbreak Investigations
Popovich, K. J., & Snitkin, E. S. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0570-0 · Cited by 56
Hagras, M., Mohammad, H. T., Mandour, M. S., Hegazy, Y. A., Ghiaty, A. H., Seleem, M. N., & Mayhoub, A. S. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00392 · Cited by 55
Pragman, A. A., Kuskowski, M. A., Abraham, J. M., & FILICE, G. A. (2012) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e318255d67c · Cited by 53
Wang, L., Liu, Y., Yang, Y., Huang, G., Wang, C., Deng, L., Zheng, Y., Fu, Z., Li, C., Shang, Y., et al. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.042663-0 · Cited by 51
Kakarla, P., Floyd, J. T., Mukherjee, M., Devireddy, A. R., Inupakutika, M. A., Ranweera, I., Ranjana, K. C., Shrestha, U., Cheeti, U. R., Willmon, T. M., et al. (2016) · Archives of Microbiology · doi:10.1007/s00203-016-1314-5 · Cited by 52
Wang, G., Li, L., Wang, X., Li, X., Zhang, Y., Yu, J., Jiang, J., You, X., & Xiong, Y. Q. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.05.002 · Cited by 54
Characterization of MRSA in Canada from 2007 to 2016
Nichol, K. A., Adam, H. J., Golding, G. R., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., Zhanel, G. G., Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD, Zhanel, G. G., Hoban, D. J., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz288 · Cited by 52
Delaney, J. A., Schneider‐Lindner, V., Brassard, P., & Suissa, S. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-2 · Cited by 59
Skin and Soft Tissue Infections
Mistry, R. D. (2013) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2013.06.011 · Cited by 54
Ellis, M. W., Griffith, M. E., Jorgensen, J. H., Hospenthal, D. R., Mende, K., & Patterson, J. E. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02352-08 · Cited by 50
Chihara, S., Popovich, K. J., Weinstein, R. A., & Hota, B. N. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-225 · Cited by 53
High prevalence of abscesses and self-treatment among injection drug users in Tijuana, Mexico
Pollini, R. A., Gallardo, M., Hasan, S., Minuto, J., Lozada, R., Vera, A., Zúñiga, M. L., & Strathdee, S. A. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.02.2238 · Cited by 51
Structural and Functional Properties of Staphylococcal Superantigen-Like Protein 4
Hermans, S. J., Baker, H. M., Sequeira, R. P., Langley, R. J., Baker, E. N., & Fraser, J. D. (2012) · Infection and Immunity · doi:10.1128/iai.00764-12 · Cited by 55
Patel, M. (2009) · Drugs · doi:10.2165/00003495-200969060-00004 · Cited by 58
Chi Thuong, T., Dac Tho, N., Thi Hoa, N., Minh Phuong, N. T., Van Tuan, L., Song Diep, T., Lindsay, J., The Dung, N., Van Cam, B., Quoc Thinh, L., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000822 · Cited by 48
Community-acquired Extended-Spectrum β-Lactamase Producers, United States
Doi, Y., Adams, J. M., O’Keefe, A., Qureshi, Z. A., Ewan, L., & Paterson, D. L. (2007) · Emerging infectious diseases · doi:10.3201/eid1307.070094 · Cited by 50
Miller, M. B., Weber, D. J., Goodrich, J. S., Popowitch, E. B., Poe, M. D., Nyugen, V., Shope, T. R., Foster, D. T., Miller, J. R., & Kotch, J. B. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02235-10 · Cited by 56
Dryden, M., Andrašević, A. T., Bassetti, M., Bouza, E., Chastre, J. E., Cornaglia, G., Esposito, S., French, G. L., Giamarellou, H., Gyssens, I. C., et al. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03135.x · Cited by 57
Tillotson, G., Draghi, D. C., Sahm, D. F., Tomfohrde, K. M., del Fabro, T., & Critchley, I. A. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn149 · Cited by 50
Peng, P., Baldry, M., Gless, B. H., Bojer, M. S., Espinosa‐Gongora, C., Baig, S., Andersen, P. S., Olsen, C. A., & Ingmer, H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02212 · Cited by 52
Shastry, L. G., Rahimian, J., & Lascher, S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.8.854 · Cited by 51
Metadata
- Authors
- Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Johns Hopkins University (US)
- Minnesota Department of Health (US)
- Emory University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-04-07
- Volume
- 352
- Issue
- 14
- Pages
- 1436-1444
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2114114837
- Cited by
- 1,493
- References
- 34
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 24 · 2023: 23 · 2022: 28 · 2021: 28 · 2020: 31 · 2019: 32 · 2018: 46 · 2017: 38 · 2016: 45 · 2015: 70 · 2014: 54 · 2013: 74 · 2012: 87
- FWCI
- 114.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Infectious Diseases › Dermatological diseases and infestations
- Keywords
- methicillin-resistant Staphylococcus aureus, skin and soft tissue infections, antimicrobial resistance, hospitalization, sentinel surveillance, Baltimore, Atlanta, Minnesota
- MeSH terms
- Adolescent, Adult, Aged, Anti-Bacterial Agents, Black or African American, Child, Child, Preschool, Drainage, Georgia, Humans, Infant, Middle Aged, Minnesota, Population Surveillance, Risk Factors, Staphylococcal Infections, Staphylococcus aureus, Baltimore, Incidence, Methicillin Resistance, Community-Acquired Infections, Endemic Diseases, Black People, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.